McCarver DG - Search Results

1

Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.

Gaedigk A, Ndjountché L, Divakaran K, Dianne Bradford L, Zineh I, Oberlander TF, Brousseau DC, McCarver DG, Johnson JA, Alander SW, Wayne Riggs K, Steven Leeder J. Gaedigk A, et al. Among authors: mccarver dg. Clin Pharmacol Ther. 2007 Feb;81(2):242-51. doi: 10.1038/sj.clpt.6100033. Clin Pharmacol Ther. 2007. PMID: 17259947

2

The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.

Brousseau DC, McCarver DG, Drendel AL, Divakaran K, Panepinto JA. Brousseau DC, et al. Among authors: mccarver dg. J Pediatr. 2007 Jun;150(6):623-6. doi: 10.1016/j.jpeds.2007.01.049. J Pediatr. 2007. PMID: 17517247 Free PMC article.

3

Human hepatic CYP2E1 expression during development.

Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG. Johnsrud EK, et al. Among authors: mccarver dg. J Pharmacol Exp Ther. 2003 Oct;307(1):402-7. doi: 10.1124/jpet.102.053124. J Pharmacol Exp Ther. 2003. PMID: 14500779

4

Identification and functional analysis of a novel human CYP2E1 far upstream enhancer.

Shadley JD, Divakaran K, Munson K, Hines RN, Douglas K, McCarver DG. Shadley JD, et al. Among authors: mccarver dg. Mol Pharmacol. 2007 Jun;71(6):1630-9. doi: 10.1124/mol.106.031302. Epub 2007 Mar 12. Mol Pharmacol. 2007. PMID: 17353354

5

Human hepatic UGT2B15 developmental expression.

Divakaran K, Hines RN, McCarver DG. Divakaran K, et al. Among authors: mccarver dg. Toxicol Sci. 2014 Sep;141(1):292-9. doi: 10.1093/toxsci/kfu126. Epub 2014 Jun 30. Toxicol Sci. 2014. PMID: 24980262 Free PMC article.

6

Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: detection of expressed protein in African-Americans.

Whetstine JR, Yueh MF, McCarver DG, Williams DE, Park CS, Kang JH, Cha YN, Dolphin CT, Shephard EA, Phillips IR, Hines RN. Whetstine JR, et al. Among authors: mccarver dg. Toxicol Appl Pharmacol. 2000 Nov 1;168(3):216-24. doi: 10.1006/taap.2000.9050. Toxicol Appl Pharmacol. 2000. PMID: 11042094

7

Alcohol dehydrogenase-2*3 allele protects against alcohol-related birth defects among African Americans.

McCarver DG, Thomasson HR, Martier SS, Sokol RJ, Li T. McCarver DG, et al. J Pharmacol Exp Ther. 1997 Dec;283(3):1095-101. J Pharmacol Exp Ther. 1997. PMID: 9399981

8

A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake.

McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. McCarver DG, et al. Toxicol Appl Pharmacol. 1998 Sep;152(1):276-81. doi: 10.1006/taap.1998.8532. Toxicol Appl Pharmacol. 1998. PMID: 9772223

9

Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).

Hines RN, Luo Z, Hopp KA, Cabacungan ET, Koukouritaki SB, McCarver DG. Hines RN, et al. Among authors: mccarver dg. J Pharmacol Exp Ther. 2003 Sep;306(3):1210-8. doi: 10.1124/jpet.103.053686. Epub 2003 Jun 26. J Pharmacol Exp Ther. 2003. PMID: 12829732

10

The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes.

Hines RN, McCarver DG. Hines RN, et al. Among authors: mccarver dg. J Pharmacol Exp Ther. 2002 Feb;300(2):355-60. doi: 10.1124/jpet.300.2.355. J Pharmacol Exp Ther. 2002. PMID: 11805191 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page